All Stories

  1. Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction
  2. A Cross‐Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction
  3. A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury
  4. The APOLLO Trial: A P roof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Ol factory Dysfunction
  5. Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics
  6. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  7. The need to promote smell health across the globe
  8. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  9. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  10. The need to promote smell health across the globe
  11. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  12. Gustatory dysfunction in dementia and cognitive decline
  13. Olfactory loss and dysfunction in dementia and cognitive decline
  14. A New Approach to Dementia
  15. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  16. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  17. Epidemiology of Cholesteatoma in the UK Biobank
  18. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  19. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  20. Epidemiology of Cholesteatoma in the UK Biobank
  21. Smell Above All: Envisioning Smell-Centred Future Worlds
  22. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  23. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  24. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  25. Obesity and Olfaction
  26. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  27. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  28. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  29. Delivery of Topical Drugs to the Olfactory Cleft
  30. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  31. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  32. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  33. Position paper on olfactory dysfunction: 2023
  34. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  35. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  36. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  37. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  38. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  39. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  40. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  41. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  42. Nose Gym: An Interactive Smell Training Solution
  43. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  44. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  45. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  46. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  47. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  48. The Nose and the Effects of SARS-CoV-2 Pandemic
  49. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  50. The EUFOREA pocket guide for chronic rhinosinusitis
  51. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  52. Investigations and Outcomes for Olfactory Disorders
  53. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  54. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  55. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  56. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  57. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  58. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  59. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  60. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  61. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  62. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  63. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  64. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  65. International consensus statement on allergy and rhinology: Olfaction
  66. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  67. Interventions for the treatment of persistent post-viral olfactory dysfunction
  68. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  69. Olfaction and CSF Leak
  70. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  71. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  72. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  73. Barriers to effective health care for patients who have smell or taste disorders
  74. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  75. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  76. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  77. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  78. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  79. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  80. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  81. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  82. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  83. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  84. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  85. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  86. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  87. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  88. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  89. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  90. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  91. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  92. Patient Experiences of Postinfectious Olfactory Dysfunction
  93. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  94. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  95. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  96. Comparison of COVID-19 and common cold chemosensory dysfunction
  97. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  98. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  99. Patient Experiences of Post-Infectious Olfactory Dysfunction
  100. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  101. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  102. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  103. Olfactory Loss of Function as a Possible Symptom of COVID-19
  104. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  105. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  106. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  107. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  108. Qualitative Olfactory Disorders: Patient experiences and self-management
  109. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  110. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  111. Parosmia is associated with relevant olfactory recovery after olfactory training
  112. The impact of patients losing their sense of smell
  113. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  114. Cholesteatoma and family history: An international survey
  115. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  116. Biologics for chronic rhinosinusitis
  117. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  118. Biologics for chronic rhinosinusitis
  119. An unmet need: Patients with smell and taste disorders
  120. 139 Risk of parkinson’s in idiopathic anosmia
  121. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  122. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  123. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  124. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  125. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  126. What is the most appropriate treatment for chronic rhinosinusitis?
  127. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  128. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  129. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  130. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  131. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  132. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  133. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  134. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  135. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  136. Wooden spatula sinusitis following maxillary expansion surgery
  137. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  138. Topical and systemic antifungal therapy for chronic rhinosinusitis
  139. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  140. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  141. Saline irrigation for allergic rhinitis
  142. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  143. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  144. Endonasal Approaches to Maxillary Sinus
  145. The use of nasal sprays and rinses in patients with chronic sinus disease
  146. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  147. Initial assessment in the management of adult epistaxis: systematic review
  148. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  149. Health care usage and quality of life reporting in chronic sinusitis patients
  150. The genetics of cholesteatoma. A systematic review using narrative synthesis
  151. Position paper on olfactory dysfunction
  152. Chronic rhinosinusitis and mood disturbance
  153. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  154. Saline irrigation for allergic rhinitis
  155. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  156. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  157. Position paper on olfactory dysfunction
  158. Chronic rhinosinusitis and mood disturbance
  159. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  160. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  161. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  162. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  163. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  164. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  165. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  166. Topical and systemic antifungal therapy for chronic rhinosinusitis
  167. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  168. SNOT-22 in a control population
  169. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  170. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  171. Genetics of Cholesteatoma Project
  172. Short-course oral steroids alone for chronic rhinosinusitis
  173. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  174. Different types of intranasal steroids for chronic rhinosinusitis
  175. Systemic and topical antibiotics for chronic rhinosinusitis
  176. Saline irrigation for chronic rhinosinusitis
  177. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  178. Chronic rhinosinusitis and mood disturbance
  179. Long term quality of life in patients with fungal sinus disease
  180. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  181. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  182. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  183. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  184. Systemic and topical antibiotics for chronic rhinosinusitis
  185. Saline irrigation for chronic rhinosinusitis
  186. Different types of intranasal steroids for chronic rhinosinusitis
  187. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  188. Short-course oral steroids alone for chronic rhinosinusitis
  189. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  190. The impact of commissioning for rhinosinusitis in England
  191. Investigation of nasal diseases
  192. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  193. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  194. Authors’ response
  195. Hyposmia
  196. Assessing the sense of smell
  197. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  198. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  199. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  200. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  201. The Impact of Olfactory Disorders in the United Kingdom
  202. Chronic Rhinosinusitis and Mood Disturbance
  203. Management of CRSwNPs Surgically
  204. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  205. SNOT-22 in a Control Population
  206. Anatomy and Physiology of the Olfactory and Gustatory Systems
  207. Cerebrospinal Fluid Rhinorrhoea
  208. Ciliary Motility Disorders
  209. Clinical Governance and Audit
  210. Complications of Sinusitis
  211. Endoscopic Sinus Surgery and Complications
  212. Epistaxis
  213. European Position Paper on Rhinosinusitis and Nasal Polyps
  214. Facial Flaps, Scars, and Keloids
  215. Facial Fractures and Swelling
  216. Fungal Sinus Disease
  217. Headache and Facial Pain
  218. Medical Statistics
  219. Microbiology of ENT
  220. Olfactory and Gustatory Disorders
  221. Sinonasal Anatomy and Physiology
  222. Tumours of the Nose and Paranasal Sinuses
  223. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  224. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  225. Unilateral cacosmia: a presentation of maxillary fungal infestation
  226. When mealtime is the most dreaded moment of your day
  227. Pneumatisation of turbinates and paranasal sinuses in children: case report
  228. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  229. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  230. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  231. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  232. A useful tool - systematic checklist for evaluating sinus scans
  233. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  234. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  235. Allergic fungal rhinosinusitis - a new staging system
  236. Allergic fungal rhinosinusitis - a new staging system
  237. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  238. Selecting the Best Approach to the Frontal Sinus
  239. Nanomedicine in otorhinolaryngology: what does the future hold?
  240. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  241. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  242. Tumefactive fibroinflammatory lesion of the frontal sinus
  243. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  244. SUBJECTS AND METHODS
  245. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  246. Proximal Lacrimal Obstruction – A Review
  247. The superosmic phenomenon
  248. The Leicester Olfactometer
  249. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  250. ENT cases seen at a local ‘walk-in centre’: a one year review
  251. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  252. A brief history of olfaction and olfactometry
  253. The superosmic phenomenon
  254. Olfactory clearance: what time is needed in clinical practice?
  255. The Effect of Female Hormone Manipulation on Nasal Physiology
  256. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  257. R152: Olfactory Adaptation and Clearance in Clinical Practice
  258. Bronchiectasis and sino-nasal disease: a review
  259. What is the short term effect of perfumes on olfactory thresholds?
  260. Which variables matter in smell tests in the clinic?
  261. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  262. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  263. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  264. Comparison of Subjective Perception with Objective Measurement of Olfaction
  265. Response to Rachmanidou
  266. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  267. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  268. Do our Noses Lead Us Away from the Scent?
  269. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  270. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  271. Is there a role for more day-case septal surgery?
  272. Erratum
  273. Canalicular adenoma of the parotid gland
  274. Paediatric retropharyngeal abscess
  275. Which solvent for olfactory testing?
  276. Nasal physiological changes during pregnancy
  277. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  278. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  279. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  280. Subjects and methods
  281. Hyposmia